| Issue |
Title |
File |
| Vol 10, No 8 (2010) |
Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors |
(Eng)
|
|
Tavakoli J., B. Aragon-Ching J.
|
| Vol 13, No 9 (2013) |
Medical Treatment Of Elderly Patients With Breast Cancer |
(Eng)
|
|
Palmeri S., Berretta M., Palmeri L.
|
| Vol 15, No 5 (2015) |
Meet Our Editor |
(Eng)
|
|
Prudhomme M.
|
| Vol 15, No 10 (2015) |
Meet Our Editorial Board Member |
(Eng)
|
|
Nagini S.
|
| Vol 15, No 4 (2015) |
Meet Our Editorial Board Member |
(Eng)
|
|
Dallemagne P.
|
| Vol 15, No 6 (2015) |
Meet Our Editorial Board Member |
(Eng)
|
|
Shtil A.
|
| Vol 16, No 10 (2016) |
Meet Our Editorial Board Member |
(Eng)
|
|
Desideri A.
|
| Vol 16, No 11 (2016) |
Meet Our Editorial Board Member |
(Eng)
|
|
Bei R.
|
| Vol 16, No 12 (2016) |
Meet Our Editorial Board Member |
(Eng)
|
|
.
|
| Vol 15, No 7 (2015) |
Meet Our Editorial Board Member: |
(Eng)
|
|
Kafarski P.
|
| Vol 15, No 8 (2015) |
Meet Our Editorial Board Member: |
(Eng)
|
|
Kohno K.
|
| Vol 16, No 1 (2016) |
Meet Our Editorial Board Member: |
(Eng)
|
|
Folini M.
|
| Vol 16, No 2 (2016) |
Meet Our Editorial Board Member: |
(Eng)
|
|
B. Aragon-Ching J.
|
| Vol 15, No 9 (2015) |
Meet Our Editorial: |
(Eng)
|
|
Campos Rosa J.
|
| Vol 24, No 6 (2024) |
Meet the Co-Editor |
(Eng)
|
|
Bei R.
|
| Vol 15, No 1 (2015) |
Meet the Editorial Board |
(Eng)
|
|
|
| Vol 15, No 3 (2015) |
Meet the Editorial Board |
(Eng)
|
|
|
| Vol 23, No 13 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Di Benedetto F.
|
| Vol 23, No 14 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Chen Y.
|
| Vol 23, No 15 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Adhikari A.
|
| Vol 23, No 16 (2023) |
Meet the Editorial Board Member |
(Eng)
|
|
Desideri A.
|
| Vol 15, No 2 (2015) |
Meet the Editorial Board: |
(Eng)
|
|
|
| Vol 12, No 3 (2012) |
Melanoma and Epigenetic Treatment: Past and Future |
(Eng)
|
|
AM La Porta C.
|
| Vol 16, No 11 (2016) |
Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts |
(Eng)
|
|
Maschio-Signorini L., Gelaleti G., Moschetta M., Borin T., Jardim-Perassi B., Lopes J., Lacerda J., Roela R., Bordin N., Corrêa L., Cardoso J., Zuccari D.
|
| Vol 25, No 15 (2025) |
Melittin, A Potential Game-changer in the Fight Against Breast Cancer: A Systematic Review |
(Eng)
|
|
Prince G., Assi A., Aoude M., Kourie H., Haddad F.
|
| Vol 15, No 3 (2015) |
Mesenchymal Stromal Cells Uptake and Release Paclitaxel without Reducing its Anticancer Activity |
(Eng)
|
|
Parati E., Alessandri G., Bagnati R., Pessina A., Mariotti M., Colognato R., Rimoldi M., Rizzetto M., Sisto F., Cocce V., Bonomi A.
|
| Vol 11, No 1 (2011) |
Metal-Based Inhibitors of Protein Tyrosine Phosphatases |
(Eng)
|
|
Lu L., Zhu M.
|
| Vol 13, No 2 (2013) |
Metformin: A Rising Star to Fight the Epithelial Mesenchymal Transition in Oncology |
(Eng)
|
|
Barriere G., Tartary M., Rigaud M.
|
| Vol 12, No 9 (2012) |
Methylenedioxy- and Ethylenedioxy-Fused Indolocarbazoles: Potent Human Topoisomerase I Inhibitors and Antitumor Agents |
(Eng)
|
|
E. Zembower D., Xie Y., Koohang A., J. Kuffel M., M. Ames M., Zhou Y., Mishra R., Aye Mar A., T. Flavin M., Xu Z.
|
| Vol 25, No 4 (2025) |
MG132-mediated Suppression of the Ubiquitin-proteasome Pathway Enhances the Sensitivity of Endometrial Cancer Cells to Cisplatin |
(Eng)
|
|
Zhang Z., Ding Y.
|
| Vol 14, No 8 (2014) |
Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche |
(Eng)
|
|
Herold-Mende C., Mock A.
|
| Vol 11, No 6 (2011) |
microRNA Involvement in Hepatocellular Carcinoma |
(Eng)
|
|
Negrini M., Gramantieri L., Sabbioni S., M. Croce C.
|
| Vol 15, No 6 (2015) |
MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview |
(Eng)
|
|
Tibaldi C., D'Incecco A., Lagana A.
|
| Vol 12, No 7 (2012) |
MicroRNAs in Cancer: Small Molecules, Big Chances |
(Eng)
|
|
Abba M., Mudduluru G., Allgayer H.
|
| Vol 14, No 3 (2014) |
Microtubule-targeting Anticancer Agents from Marine Natural Substance |
(Eng)
|
|
Liu Z., Xu P., Wu T., Zeng W.
|
| Vol 14, No 6 (2014) |
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2 |
(Eng)
|
|
Yang M., Shan X., Zhou X., Qiu T., Zhu W., Ding Y., Shu Y., Liu P.
|
| Vol 14, No 1 (2014) |
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells |
(Eng)
|
|
Golubovskaya V., Sumbler B., Ho B., Yemma M., Cance W.
|
| Vol 14, No 1 (2014) |
MiR-138 and MiR-135 Directly Target Focal Adhesion Kinase, Inhibit Cell Invasion, and Increase Sensitivity to Chemotherapy in Cancer Cells |
(Eng)
|
|
Golubovskaya V., Sumbler B., Ho B., Yemma M., Cance W.
|
| Vol 11, No 2 (2011) |
Mitochondrial Superoxide Dismutase - Signals of Distinction |
(Eng)
|
|
Miriyala S., K. Holley A., St Clair D.K.
|
| Vol 15, No 10 (2015) |
Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer |
(Eng)
|
|
Yuan J., Kang J., Liao H., Wang X., Nie M., Shuai R., Deng C.
|
| Vol 13, No 4 (2013) |
Mitoxantrone Targets the ATP-binding Site of FAK, Binds the FAK Kinase Domain and Decreases FAK, Pyk-2, c-Src, and IGF-1R In Vitro Kinase Activities |
(Eng)
|
|
M. Golubovskaya V., Ho B., Zheng M., Magis A., Ostrov D., G. Cance W.
|
| Vol 12, No 7 (2012) |
MMPs in Ovarian Cancer as Therapeutic Targets |
(Eng)
|
|
Karam A., Dorigo O.
|
| Vol 14, No 7 (2014) |
Modeling Study of Phenylsulfonylfuroxan Derivatives as P-gp Inhibitors: A Combined Approach of CoMFA, CoMSIA and HQSAR |
(Eng)
|
|
Gadhe C., Balupuri A., Balasubramanian P., Cho S.
|
| Vol 24, No 5 (2024) |
Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants |
(Eng)
|
|
Akkulak M., Evin E., Durukan O., Celebioglu H., Adali O.
|
| Vol 14, No 8 (2014) |
Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates |
(Eng)
|
|
Refolo M., D'Alessandro R., Lippolis C., Messa C., Carella N., Cavallini A., Carr B.
|
| Vol 11, No 3 (2011) |
Modulation of Histone Acetylation by Garlic Sulfur Compounds |
(Eng)
|
|
Druesne-Pecollo N., Latino-Martel P.
|
| Vol 12, No 7 (2012) |
Modulation of MMPs by Cell Surface Integrin Receptor α5β1 |
(Eng)
|
|
Pal S., Kumar Ganguly K., Moulik S., Chatterjee A.
|
| Vol 24, No 17 (2024) |
Molecular Actions of Enicostemma hyssopifolium Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells |
(Eng)
|
|
Koralahalli K., Hussain S., Devarajan D., Siddikuzzaman ., Mariammal B.
|
| Vol 24, No 20 (2024) |
Molecular Activities and Mechanisms of Action of Substances and Molecules from Medicinal Plants from Sub-Saharan Africa on Prostate and Cervical Cancer Cells |
(Eng)
|
|
Coulibaly L.L., Bayala B., Simpore J.
|
| Vol 25, No 17 (2025) |
Molecular Dynamics (MD) Simulation of GPR87-LPA Binding: Therapeutic Implications for Targeted Cancer Treatment |
(Eng)
|
|
Rani M., Sharma A., Nischal A., Khattri S., Sahoo G., Singh R.
|
| Vol 13, No 7 (2013) |
Molecular Evidence of Cryptotanshinone for Treatment and Prevention of Human Cancer |
(Eng)
|
|
Chen W., Lu Y., Chen G., Huang S.
|
| Vol 11, No 1 (2011) |
Molecular Field Analysis (MFA) and Other QSAR Techniques in Development of Phosphatase Inhibitors |
(Eng)
|
|
C. Nair P.
|
| Vol 12, No 5 (2012) |
Molecular Imaging of Cancer with Radiolabeled Peptides and PET |
(Eng)
|
|
L. Vavere A., Rossin R.
|
| Vol 24, No 18 (2024) |
Molecular Imaging of Melanoma VEGF-expressing Tumors through [99mTc]Tc-HYNIC-Fab(Bevacizumab) |
(Eng)
|
|
Fernández M., Reyes A.L., Paolino A., Savio E., Cerecetto H., Cabral P., Gambini J., Camacho X., Perroni C., Alfaya L., Cabrera M., Tassano M., García M.
|
| Vol 14, No 9 (2014) |
Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin |
(Eng)
|
|
Goncalves N., Rodrigues R., Jardim-Perassi B., Moschetta M., Lopes J., Colombo J., Zuccari D.
|
| Vol 15, No 4 (2015) |
Molecular Mechanism Behind the Synergistic Activity of Diphenylmethyl Selenocyanate and Cisplatin Against Murine Tumor Model |
(Eng)
|
|
Chakraborty P., Roy S., Bhattacharya S.
|
| Vol 11, No 4 (2011) |
Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma |
(Eng)
|
|
Karmakar S., Roy Choudhury S., L. Banik N., K. Ray S.
|
| Vol 16, No 11 (2016) |
Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer |
(Eng)
|
|
Jiang S., Ling C., Li W., Jiang H., Zhi Q., Jiang M.
|
| Vol 23, No 10 (2023) |
Molecular Mechanisms of Chloroquine and Hydroxychloroquine Used in Cancer Therapy |
(Eng)
|
|
De Sanctis J., Charris J., Blanco Z., Ramírez H., Martínez G., Mijares M.
|
| Vol 11, No 6 (2011) |
Molecular Mechanisms of Liver Cancer |
(Eng)
|
|
Pan H., Fu X., Huang W.
|
| Vol 12, No 3 (2012) |
Molecular Probing and Imaging of Histone Deacetylase Inhibitors in Cancer Treatment |
(Eng)
|
|
Jiaguo H., Zhiguo L., Wenbin Z.
|
| Vol 13, No 3 (2013) |
Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives |
(Eng)
|
|
Bozec A., Peyrade F., Milano G.
|
| Vol 15, No 7 (2015) |
Molecular Targets of Omega-3 Fatty Acids for Cancer Therapy |
(Eng)
|
|
Devi K., Rajavel T., Russo G., Daglia M., Nabavi S., Nabavi S.
|
| Vol 25, No 5 (2025) |
Molecular Targets of Plant-based Alkaloids and Polyphenolics in Liver and Breast Cancer- An Insight into Anticancer Drug Development |
(Eng)
|
|
Batool S., Asim L., Qureshi F., Masood A., Mushtaq M., Saleem R.
|
| Vol 15, No 6 (2015) |
Molecular Treatment of Different Breast Cancers |
(Eng)
|
|
Wang Y., Cao S., Chen Y.
|
| Vol 24, No 13 (2024) |
Monochasma Savatieri Aqueous Extract inhibits Human Breast Cancer Cell Line Migration and Adhesion Without Generating Toxicity |
(Eng)
|
|
Tan L., Solis-Sainz J.
|
| Vol 24, No 14 (2024) |
Moscatilin Reverses EMT Progression and its Resulting Enhanced Invasion and Migration by Affecting the TGF-β Signaling Pathway in Bladder Cancer |
(Eng)
|
|
Li Z., Yang J., Chen L., Chen P., Liu C., Long X., Chen B., Long J.
|
| Vol 15, No 4 (2015) |
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance |
(Eng)
|
|
Li S., Zhang W., Yin X., Xing S., Xie H., Cao Z., Zhao B.
|
| Vol 10, No 6 (2010) |
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets |
(Eng)
|
|
Kondo T.
|
| Vol 13, No 6 (2013) |
Multidisciplinary Approach to Patient with Malignant Melanoma |
(Eng)
|
|
Scarpati G., Fusciello C., Sabbatino F., Ferrone S., Caponigro F., Perri F., Carlomagno C., Pepe S.
|
| Vol 13, No 6 (2013) |
Multidisciplinary Approach to Rectal Cancer: Are we Ready for Selective Treatment Strategies? |
(Eng)
|
|
Avallone A., Aloj L., Delrio P., Pecori B., Leone A., Tatangelo F., Perri F., Petrillo A., Scott N., Budillon A.
|
| Vol 13, No 6 (2013) |
Multidisciplinary Treatment of Early Stage Endometrial Cancer |
(Eng)
|
|
Cecere S., Pisano C., Bamias A., Napoli M., Rossetti S., Facchini G., Tambaro R., Pignata S.
|
| Vol 13, No 3 (2013) |
Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy |
(Eng)
|
|
Li H., Wang J., Huang G., Wang P., Zheng R., Zhang C., Jiang Q.
|
| Vol 10, No 2 (2010) |
Multiple Myeloma: A Paradigm for Translation of the Cancer Stem Cell Hypothesis |
(Eng)
|
|
Agarwal J., Matsui W.
|
| Vol 23, No 20 (2023) |
Multivariate Statistical 2D QSAR Analysis of Indenoisoquinoline-based Topoisomerase- I Inhibitors as Anti-lung Cancer Agents |
(Eng)
|
|
Singh S., Mangla B., Javed S., Kumar P., Ahsan W.
|
| Vol 13, No 8 (2013) |
Muscarinic Activation Enhances the Anti-proliferative Effect of Paclitaxel in Murine Breast Tumor Cells |
(Eng)
|
|
Español A., Jacob G., Dmytrenko G., Sales M.
|
| Vol 16, No 12 (2016) |
Mutant B-Raf Kinase Inhibitors as Anticancer Agents |
(Eng)
|
|
Asati V., Bharti S., Mahapatra D.
|
| Vol 13, No 10 (2013) |
Myricetin Induces Apoptosis in HepG2 Cells Through Akt/p70S6K/Bad Signaling and Mitochondrial Apoptotic Pathway |
(Eng)
|
|
Zhang X., Chen S., Tang L., Shen Y., Luo L., Xu C., Liu Q., Li D.
|
| Vol 13, No 4 (2013) |
N6-Isopentenyladenosine and its Analogue N6-Benzyladenosine Induce Cell Cycle Arrest and Apoptosis in Bladder Carcinoma T24 Cells |
(Eng)
|
|
Castiglioni S., Casati S., Ottria R., Ciuffreda P., A.M. Maier J.
|
| Vol 23, No 12 (2023) |
NAD+ Consuming Enzymes: Involvement in Therapies and Prevention of Human Diseases |
(Eng)
|
|
Masutani M., Miwa M., Poltronieri P.
|
| Vol 13, No 3 (2013) |
NADPH Oxidases NOXs and DUOXs as Putative Targets for Cancer Therapy |
(Eng)
|
|
Weyemi U., E. Redon C., R. Parekh P., Dupuy C., M. Bonner W.
|
| Vol 14, No 6 (2014) |
Nanoparticle-Delivered Quercetin for Cancer Therapy |
(Eng)
|
|
Men K., Duan X., Wei X., Gou M., Huang M., Chen L., Qian Z., Wei Y.
|
| Vol 11, No 7 (2011) |
Nanoparticles in Oncology: The New Theragnostic Molecules |
(Eng)
|
|
Allegra A., Penna G., Alonci A., Rizzo V., Russo S., Musolino C.
|
| Vol 24, No 8 (2024) |
Nanotechnology Utilizing Ferroptosis Inducers in Cancer Treatment |
(Eng)
|
|
Farzipour S., Jalali Zefrei F., Bahadorikhalili S., Alvandi M., Salari A., Shaghaghi Z.
|
| Vol 15, No 10 (2015) |
Natural and Induced Antibody Polyreactivity |
(Eng)
|
|
Jarossay A., Hadzhieva M., Kaveri S., Lacroix-Desmazes S., Dimitrov J.
|
| Vol 24, No 16 (2024) |
Natural Compounds as Protease Inhibitors in Therapeutic Focus on Cancer Therapy |
(Eng)
|
|
Kakali B.
|
| Vol 13, No 10 (2013) |
Natural Compounds with Cell Growth Inhibitory Activity in Human Tumor Cell Lines |
(Eng)
|
|
Cazal C., Choosang K., Severino V., Fernandes J., Silva M., Vieira P., Nascimento M., Almeida G., Vasconcelos M., Pakkong P., Pinto M.
|
| Vol 13, No 6 (2013) |
Natural Flora and Anticancer Regime: Milestones and Roadmap |
(Eng)
|
|
Bhatnagar I., Thomas N., Kim S.
|
| Vol 16, No 10 (2016) |
Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents |
(Eng)
|
|
Yu B., Zheng Y., Shi X., Qi P., Liu H.
|
| Vol 23, No 13 (2023) |
Natural Products and Gastric Cancer: Cellular Mechanisms and Effects to Change Cancer Progression |
(Eng)
|
|
Zhao N., Wang W., Jiang H., Qiao Z., Sun S., Wei Y., Xie X., Li H., Bi X., Yang Z.
|
| Vol 13, No 7 (2013) |
Natural Products Targeting Autophagy via the PI3K/Akt/mTOR Pathway as Anticancer Agents |
(Eng)
|
|
Sun H., Wang Z., Yakisich J.
|
| Vol 12, No 1 (2012) |
Natural Products: Promising Resources for Cancer Drug Discovery |
(Eng)
|
|
Mondal S., Bandyopadhyay S., K. Ghosh M., Mukhopadhyay S., Roy S., Mandal C.
|
| Vol 12, No 8 (2012) |
Natural-derived Polyphenols as Potential Anticancer Agents |
(Eng)
|
|
Spatafora C., Tringali C.
|
| Vol 13, No 8 (2013) |
Naturally-occurring Dimers of Flavonoids as Anticarcinogens |
(Eng)
|
|
Mercader A., Pomilio A.
|
| Vol 14, No 3 (2014) |
Nature Promises New Anticancer Agents: Interplay with the Apoptosis-related BCL2 Gene Family |
(Eng)
|
|
Christodoulou M., Kontos C., Halabalaki M., Skaltsounis A., Scorilas A.
|
| Vol 25, No 12 (2025) |
N-Degron PROTACs as a Potential Therapeutic Approach for Chronic Myeloid Leukemia |
(Eng)
|
|
Hohman G., Eldeeb M.
|
| Vol 15, No 9 (2015) |
Neddylation Pathway as a Novel Anti-cancer Target: Mechanistic Investigation and Therapeutic Implication |
(Eng)
|
|
Jiang Y., Jia L.
|
| Vol 15, No 1 (2015) |
Neoadjuvant Strategies for Triple Negative Breast Cancer: 'State-of-the-art' and Future Perspectives |
(Eng)
|
|
Carbognin L., Furlanetto J., Vicentini C., Nortilli R., Pilotto S., Brunelli M., Pellini F., Pollini G., Bria E., Tortora G.
|
| Vol 11, No 5 (2011) |
Neuropilin and Neuropilin Associated Molecules as New Molecular Targets in Pancreatic Adenocarcinoma |
(Eng)
|
|
H. Muders M.
|
| Vol 12, No 6 (2012) |
Neutrophil Elastase as a Target in Lung Cancer |
(Eng)
|
|
Moroy G., J.P. Alix A., Sapi J., Hornebeck W., Bourguet E.
|
| 701 - 800 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
